| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.19B | -8.4% |
| Cost of Revenue | $1.52B | -2.4% |
| Gross Profit | $668.0M | -19.5% |
| R&D Expense | $51.0M | -7.3% |
| SG&A Expense | $365.0M | -7.1% |
| Operating Income | $172.0M | -48.3% |
| Interest Expense | $3.0M | -25.0% |
| Pre-tax Income | $160.0M | -22.3% |
| Income Tax | -$8.0M |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $417.0M | -35.4% |
| Accounts Receivable | $338.0M | -15.9% |
| Inventory | $626.0M | -0.5% |
| Current Assets | $1.51B | -14.8% |
| Total Assets | $5.94B | -4.4% |
| Current Liabilities | $456.0M | -17.5% |
| Long-term Debt | $1.31B | +3.5% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Capital Expenditures | $170.0M | +50.4% |
| Financing Cash Flow | -$371.0M | +58.6% |
| -132.0% |
| Net Income | $178.0M | -80.8% |
| EPS (Basic) | $3.36 | -79.9% |
| EPS (Diluted) | $3.31 | -79.8% |
| Stockholders' Equity |
| $3.10B |
| -3.8% |